{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:44:17Z","timestamp":1788403457361,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1123499"],"award-info":[{"award-number":["APP1123499"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R34AI136815"],"award-info":[{"award-number":["R34AI136815"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM7347"],"award-info":[{"award-number":["T32 GM7347"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI139021"],"award-info":[{"award-number":["R21AI139021"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30 AI131780"],"award-info":[{"award-number":["F30 AI131780"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P50GM115305-01"],"award-info":[{"award-number":["1P50GM115305-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jmoldx.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T20:03:41Z","timestamp":1559333021000},"page":"782-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms"],"prefix":"10.1016","volume":"21","author":[{"given":"Francois X.","family":"Rwandamuriye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Konvinse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Mallal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2019.04.006_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tan.13183","article-title":"HLAs: key regulators of T-cell-mediated drug hypersensitivity","volume":"91","author":"Redwood","year":"2018","journal-title":"HLA"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib3","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.4049\/jimmunol.1302101","article-title":"HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity","volume":"191","author":"Paul","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciu126","article-title":"Severe cutaneous adverse reactions related to systemic antibiotics","volume":"58","author":"Lin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib7","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-med-050913-022745","article-title":"T cell-mediated hypersensitivity reactions to drugs","volume":"66","author":"Pavlos","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib10","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.humimm.2016.04.002","article-title":"Next-generation sequencing of the HLA locus: methods and impacts on HLA typing, population genetics and disease association studies","volume":"77","author":"Carapito","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1034\/j.1399-0039.2001.057001046.x","article-title":"HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors","volume":"57","author":"Sayer","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/clpt.2008.89","article-title":"Development of a large-scale de-identified DNA biobank to enable personalized medicine","volume":"84","author":"Roden","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib13","doi-asserted-by":"crossref","first-page":"e0172444","DOI":"10.1371\/journal.pone.0172444","article-title":"Comparison of HLA allelic imputation programs","volume":"12","author":"Karnes","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bdq.2017.10.001","article-title":"Amplification of nonspecific products in quantitative polymerase chain reactions (qPCR)","volume":"14","author":"Ruiz-Villalba","year":"2017","journal-title":"Biomol Detect Quantif"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygeno.2007.10.016","article-title":"Locked nucleic acids in PCR primers increase sensitivity and performance","volume":"91","author":"Ballantyne","year":"2008","journal-title":"Genomics"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0198-8859(01)00298-1","article-title":"Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations","volume":"62","author":"Cao","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between HLA-B*57:01, HLA-DR7 and HLA-DQ3 and hypersensitivity to HIV-1 reverse transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib19","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1744-313X.2011.01040.x","article-title":"Human leucocyte antigen typing: techniques and technology, a critical appraisal","volume":"38","author":"Dunn","year":"2011","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4168\/aair.2017.9.1.79","article-title":"Validation of a rapid, robust, inexpensive screening method for detecting the HLA-B*58:01 allele in the prevention of allopurinol-induced severe cutaneous adverse reactions","volume":"9","author":"Nguyen","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.humimm.2016.08.010","article-title":"Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis in individuals of Asian ancestry","volume":"77","author":"Nguyen","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2133\/dmpk.DMPK-12-NT-136","article-title":"Development of a simple method for detection of the HLA-A*31:01 allele","volume":"28","author":"Uchiyama","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-0039.2007.00840.x","article-title":"HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay","volume":"70","author":"Hammond","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/tan.12863","article-title":"A multiplex allele-specific real-time polymerase chain reaction assay for HLA-B*13:01 genotyping in four Chinese populations","volume":"88","author":"Liu","year":"2016","journal-title":"HLA"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2217\/pgs.10.77","article-title":"Pharmacogenetics of drug hypersensitivity","volume":"11","author":"Phillips","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","article-title":"Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations","volume":"9","author":"Ferrell","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jmoldx.2019.04.006_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/135965350701200708","article-title":"External quality assessment of HLA-B*5701 reporting: an international multicentre survey","volume":"12","author":"Hammond","year":"2007","journal-title":"Antivir Ther"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157819300765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157819300765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:20Z","timestamp":1778616440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157819300765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1525157819300765"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2019.04.006","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}